Abstract
IntroductionApplication of liquid embolic agents (LEAs) is a method of choice for endovascular treatment of cerebral arteriovenous malformations (AVMs). Nonadhesive agents (Onyx®Medtronic, USA; Squid®Balt, France) are preferred. Thanks to the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
